Search

everythinglearnresearchcommunity

for

Search:↓

Disease-specific tools better assess quality of life in alopecia areata patients.

The Breast Utility Instrument was developed to assess quality of life in breast cancer patients.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

The questionnaire is valid and reliable but needs more testing for future predictions.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Seborrheic dermatitis lowers quality of life more for women, younger people, and those with more education.

Alopecia areata greatly affects the quality of life for children and their families.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Poor air quality increases the risk of atopic dermatitis in Taiwan.

The Graft Quality Index grades hair transplant grafts to predict placement difficulty and surgery results.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Hair disorders significantly reduce quality of life.

European dermatological guidelines vary in quality, with some highly rated, but improvements are needed in applicability and consistency.

Women with skin conditions who have body image concerns often experience mental health issues and a lower quality of life.

The HAIR-Q is a reliable tool for assessing patient satisfaction with hair loss treatments.

The study created a numerical system to describe and compare 601 jobs in Japan.

Alopecia negatively affects quality of life and mental health.

The Polish version of the Alopecia Areata Quality of Life Index is a reliable tool for assessing quality of life in Polish-speaking patients with alopecia areata.

A new tool helps lupus patients and doctors better track symptoms and quality of life.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Skin changes in Pseudoxanthoma elasticum patients can indicate the severity of related health issues.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

Current tools inadequately measure quality of life in children with alopecia areata, needing better instruments.

Alopecia areata greatly affects quality of life, especially mental health, and newer assessment tools better capture this impact than older ones.

Hair loss from alopecia areata and androgenetic alopecia moderately affects the quality of life, especially in younger patients and those with long-term hair loss, impacting both their physical and emotional well-being.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.